+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

eClinical Solutions Market by Product, Development Phase, Delivery Mode, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5337404
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The eClinical Solutions Market grew from USD 9.08 billion in 2023 to USD 10.31 billion in 2024. It is expected to continue growing at a CAGR of 13.96%, reaching USD 22.69 billion by 2030.

eClinical solutions encompass software and technology applications aimed at managing and accelerating clinical trials within the pharmaceutical and biotechnology industries. These solutions facilitate the collection, management, and analysis of clinical trial data by leveraging advanced analytics, artificial intelligence, and cloud technologies. Their necessity stems from the need to streamline traditional paper-based processes into digital formats to enhance efficiencies, reduce costs, and improve data accuracy. Applications are widespread, ranging from clinical data management systems (CDMS) and electronic data capture (EDC) to clinical trial management systems (CTMS) and randomization tools. The end-use scope includes pharmaceutical companies, contract research organizations (CROs), and academic research institutions.

The market is influenced by the growing complexity of clinical trials, increasing R&D investments, and the pharmaceutical industry's shift towards personalized medicine. Additionally, regulatory mandates for clinical data standardization propel the demand for these solutions. Among the latest opportunities, the advent of artificial intelligence and machine learning provides new potentials for predictive analytics in trials, enhancing data-driven decision-making. To seize these opportunities, organizations may focus on integrating big data analytics and adopting flexible, interoperable platforms to accommodate digital transitions.

Challenges include high upfront costs, data privacy concerns, and the integration of diverse eClinical solutions within existing systems. Moreover, regulatory compliance across different regions often requires significant adaptation efforts, posing hurdles for market players. The need for skilled professionals to manage and interpret sophisticated data analytics is another potential bottleneck.

For innovation and research, focusing on blockchain for enhanced data transparency and security, and refining AI algorithms for patient recruitment and trial design, are promising areas. The nature of the market is characterized by rapid technological advancements and a competitive landscape with significant collaborations and partnerships. Overall, the emphasis on digital transformation and personalized patient care is likely to drive continued investment and innovation in eClinical solutions.

Understanding Market Dynamics in the eClinical Solutions Market

The eClinical Solutions Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising research and development activities by pharma and biopharma companies
    • Increasing integration of IoT and AI in the pharmaceutical sector
    • Presence of a stringent regulatory structure for clinical trials
  • Market Restraints
    • High cost of implementation of eClinical solutions
  • Market Opportunities
    • Introduction of technologically advanced eClinical solutions
    • Increasing incorporation of software in eClinical solutions
  • Market Challenges
    • Software reliability and patent privacy issues associated with eClinical solutions

Exploring Porter’s Five Forces for the eClinical Solutions Market

Porter’s Five Forces framework further strengthens the insights of the eClinical Solutions Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the eClinical Solutions Market

External macro-environmental factors deeply influence the performance of the eClinical Solutions Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the eClinical Solutions Market

The eClinical Solutions Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the eClinical Solutions Market

The eClinical Solutions Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the eClinical Solutions Market

The eClinical Solutions Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the eClinical Solutions Market, highlighting leading vendors and their innovative profiles. These include 4G Clinical, Acceliant, Advarra, Inc., Anju Software, Inc., ArisGlobal LLC, BSI Business Systems Integration AG, Castor Research Inc., Clinion, Dassault Systèmes S.E., eClinical Solutions LLC, EvidentIQ Group GmbH, Fountayn, ICON PLC, International Business Machines Corporation, IQVIA Inc., KPS Life, LLC, MaxisIT Inc., MedNet Solutions, Inc., Medrio, Inc., Microsoft Corporation, Octalsoft, Oracle Corporation, Parexel International Corporation, RealTime Software Solutions, LLC, Research Solutions, Inc., Saama Technologies, LLC, Signant Health, Sitero, and Veeva Systems Inc..

Market Segmentation & Coverage

This research report categorizes the eClinical Solutions Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Clinical Analytics Platforms
    • Clinical Data Integration Platforms
    • Clinical Trial Management Systems
    • Electronic Clinical Outcome Assessment
    • Electronic Consent
    • Electronic Data Capture & Clinical Data Management Systems
    • Electronic Trial Master File
    • Randomization and Trial Supply Management
    • Safety Solutions
  • Development Phase
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
  • Delivery Mode
    • Cloud
    • On-premise
  • End-User
    • Academic Institutes
    • Contract Research Organization
    • Hospitals
    • Medical Device Manufacturers
    • Pharma & Biotech Organizations
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising research and development activities by pharma and biopharma companies
5.1.1.2. Increasing integration of IoT and AI in the pharmaceutical sector
5.1.1.3. Presence of a stringent regulatory structure for clinical trials
5.1.2. Restraints
5.1.2.1. High cost of implementation of eClinical solutions
5.1.3. Opportunities
5.1.3.1. Introduction of technologically advanced eClinical solutions
5.1.3.2. Increasing incorporation of software in eClinical solutions
5.1.4. Challenges
5.1.4.1. Software reliability and patent privacy issues associated with eClinical solutions
5.2. Market Segmentation Analysis
5.2.1. Product: Growing adoption of clinical analytics platforms to aid in better decision-making throughout the clinical trial process
5.2.2. End-User: Rising deployment of eClinical solutions in pharma & biotech organizations to manage large-scale multi-site trials
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. eClinical Solutions Market, by Product
6.1. Introduction
6.2. Clinical Analytics Platforms
6.3. Clinical Data Integration Platforms
6.4. Clinical Trial Management Systems
6.5. Electronic Clinical Outcome Assessment
6.6. Electronic Consent
6.7. Electronic Data Capture & Clinical Data Management Systems
6.8. Electronic Trial Master File
6.9. Randomization and Trial Supply Management
6.10. Safety Solutions
7. eClinical Solutions Market, by Development Phase
7.1. Introduction
7.2. Phase I
7.3. Phase II
7.4. Phase III
7.5. Phase IV
8. eClinical Solutions Market, by Delivery Mode
8.1. Introduction
8.2. Cloud
8.3. On-premise
9. eClinical Solutions Market, by End-User
9.1. Introduction
9.2. Academic Institutes
9.3. Contract Research Organization
9.4. Hospitals
9.5. Medical Device Manufacturers
9.6. Pharma & Biotech Organizations
10. Americas eClinical Solutions Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific eClinical Solutions Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa eClinical Solutions Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Revolutionizing Clinical Trial Data Management with Revvity Signals Clinical Solution
13.3.2. Clario Divests Software Solutions Unit to Sitero, Refocusing on Core Clinical Technologies
13.3.3. Strategic Acquisition Enhances End-to-End Clinical Research Solutions
13.3.4. Almac Unveils iXRS3 Partnership Network to Enhance Clinical Trial Management for Sponsors and CROs
13.3.5. Clinion Introduced AI-Driven Solution for Medical Coding in Clinical Trials
13.3.6. ResoluteAI Unveils Cutting-Edge Clinical Trial Analytics Platform to Enhance Drug Development Efficiency
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. ECLINICAL SOLUTIONS MARKET RESEARCH PROCESS
FIGURE 2. ECLINICAL SOLUTIONS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 13. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES ECLINICAL SOLUTIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES ECLINICAL SOLUTIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. ECLINICAL SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. ECLINICAL SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. ECLINICAL SOLUTIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. ECLINICAL SOLUTIONS MARKET DYNAMICS
TABLE 7. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL ANALYTICS PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL DATA INTEGRATION PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY ELECTRONIC CLINICAL OUTCOME ASSESSMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY ELECTRONIC CONSENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY ELECTRONIC DATA CAPTURE & CLINICAL DATA MANAGEMENT SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY ELECTRONIC TRIAL MASTER FILE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY SAFETY SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLOUD, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY MEDICAL DEVICE MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PHARMA & BIOTECH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. CANADA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. CANADA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 46. CANADA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 47. CANADA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. MEXICO ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. MEXICO ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 50. MEXICO ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 51. MEXICO ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES ECLINICAL SOLUTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. CHINA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. CHINA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 68. CHINA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 69. CHINA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. INDIA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 71. INDIA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 72. INDIA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 73. INDIA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. INDONESIA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. INDONESIA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 76. INDONESIA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 77. INDONESIA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. JAPAN ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. JAPAN ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 80. JAPAN ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 81. JAPAN ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. MALAYSIA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. MALAYSIA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 84. MALAYSIA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 85. MALAYSIA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. PHILIPPINES ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. PHILIPPINES ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 88. PHILIPPINES ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 89. PHILIPPINES ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. SINGAPORE ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. SINGAPORE ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 92. SINGAPORE ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 93. SINGAPORE ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. SOUTH KOREA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. SOUTH KOREA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 96. SOUTH KOREA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 97. SOUTH KOREA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. TAIWAN ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. TAIWAN ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 100. TAIWAN ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 101. TAIWAN ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. THAILAND ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. THAILAND ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 104. THAILAND ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 105. THAILAND ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. VIETNAM ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. VIETNAM ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 108. VIETNAM ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 109. VIETNAM ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 115. DENMARK ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. DENMARK ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 117. DENMARK ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 118. DENMARK ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. EGYPT ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. EGYPT ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 121. EGYPT ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 122. EGYPT ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. FINLAND ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. FINLAND ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 125. FINLAND ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 126. FINLAND ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. FRANCE ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. FRANCE ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 129. FRANCE ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 130. FRANCE ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. GERMANY ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. GERMANY ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 133. GERMANY ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 134. GERMANY ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. ISRAEL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. ISRAEL ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 137. ISRAEL ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 138. ISRAEL ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. ITALY ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. ITALY ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 141. ITALY ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 142. ITALY ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. NETHERLANDS ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 144. NETHERLANDS ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 145. NETHERLANDS ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 146. NETHERLANDS ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. NIGERIA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. NIGERIA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 149. NIGERIA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 150. NIGERIA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. NORWAY ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 152. NORWAY ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 153. NORWAY ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 154. NORWAY ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. POLAND ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. POLAND ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 157. POLAND ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 158. POLAND ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 159. QATAR ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 160. QATAR ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 161. QATAR ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 162. QATAR ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 166. RUSSIA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 168. SAUDI ARABIA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 169. SAUDI ARABIA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 170. SAUDI ARABIA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 172. SOUTH AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 173. SOUTH AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 174. SOUTH AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. SPAIN ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 176. SPAIN ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 177. SPAIN ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 178. SPAIN ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 182. SWEDEN ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 183. SWITZERLAND ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 184. SWITZERLAND ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 185. SWITZERLAND ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 186. SWITZERLAND ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. TURKEY ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 188. TURKEY ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 189. TURKEY ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 190. TURKEY ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 196. UNITED KINGDOM ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 198. UNITED KINGDOM ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 199. ECLINICAL SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 200. ECLINICAL SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the eClinical Solutions Market, which are profiled in this report, include:
  • 4G Clinical
  • Acceliant
  • Advarra, Inc.
  • Anju Software, Inc.
  • ArisGlobal LLC
  • BSI Business Systems Integration AG
  • Castor Research Inc.
  • Clinion
  • Dassault Systèmes S.E.
  • eClinical Solutions LLC
  • EvidentIQ Group GmbH
  • Fountayn
  • ICON PLC
  • International Business Machines Corporation
  • IQVIA Inc.
  • KPS Life, LLC
  • MaxisIT Inc.
  • MedNet Solutions, Inc.
  • Medrio, Inc.
  • Microsoft Corporation
  • Octalsoft
  • Oracle Corporation
  • Parexel International Corporation
  • RealTime Software Solutions, LLC
  • Research Solutions, Inc.
  • Saama Technologies, LLC
  • Signant Health
  • Sitero
  • Veeva Systems Inc.

Methodology

Loading
LOADING...

Table Information